Prognostic significance of ki-67 nuclear proliferative antigen, bcl-2 protein, and p53 expression in follicular and diffuse large b-cell lymphoma

Medical Oncology

Volumn 18, Issue 1, 2001, Pages 15-22

  Llanos, Marta ^a   Alvarez Argüelles, Hugo ^a   Alemán, Remedios ^a   Oramas, Juana ^a   Díaz Flores, Lucio ^a   Batista, Norberto ^a  

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

Author keywords

Bcl 2; Immunohistochemistry; Ki 67; Lymphoma; P53; Prognosis

Indexed keywords

KI 67 ANTIGEN; LACTATE DEHYDROGENASE; MONOCLONAL ANTIBODY; PROTEIN BCL 2; PROTEIN P53;

ADULT; AGE; AGED; ANTIGEN EXPRESSION; ARTICLE; B CELL LYMPHOMA; CANCER GRADING; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; FOLLICULAR LYMPHOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

ADULT; AGED; ANTIBODIES, MONOCLONAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL, DIFFUSE; MALE; MIDDLE AGED; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; SURVIVAL ANALYSIS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0034801831     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1385/MO:18:1:15     Document Type: Article

References (33)

1. A predictive model for aggressive non-Hodkin's lymphoma
2. A new serologic lymphomas based on initial β2-microglobulin and lactate dehydrogenase levels
3. Prognostic significance of bcl-2 protein expression in aggressive non-Hodgkin's lymphoma
4. Prognostic significance of bcl-2 expression and bcl-2 major breakpoint region rearrangement in diffuse large cell non-Hodgkin's lymphoma: A British National Lymphoma Investigation study
5. Relationship of p53, bcl-2, and tumor proliferation to clinical drug resistance in non-Hodgkin's lymphomas
6. Clinical significance of bcl-2 and p53 protein expression in diffuse large B-cell lymphoma; a population based study
7. Bcl-2 and p53 protein expression in follicular lymphoma
8. p53 mutation is associated with progression in follicular lymphomas
9. p53 mutation and expression in lymphoma
10. Large cell variants of mantle cell lymphoma: Cytologic characteristics and p53 anomalies may predict poor outcome
11. P53 mutations in mantle cell lymphoma are associated with variant cytology and predict a poor prognosis
12. Correlation between mutation in p53, p53 expression, cytogenetics, histologic type, and survival in patients with B-cell non-Hodgkin's lymphoma
13. The prognostic value of Ki67 immunostaging in non-Hodgkin's lymphoma
14. Independent prognostic significance of a nuclear proliferation antigen in diffuse large cell lymphomas as determined by the monoclonal antibody Ki67
15. Prognostic significance of the Ki67 associated proliferate antigen in aggressive non-Hodgkin's lymphomas: A prospective Southwest Oncology Group Trial
16. Immunohisto-chemistry of lymphoma
17. Proliferative index in breast carcinoma determined in situ by ki67 immunostaining and its relationship to clinical and pathological variables
18. Nonparametric estimation from incomplete observations
19. Asymptotically efficient rank invariant test procedures
20. Regressions model and life tables
21. Lymphoma classification: The gap between biology and clinical management is closing
22. Pathologic prognostic factors in diffuse aggressive non-Hodgkin's lymphoma
23. Factores pronósticos en los linfomas no Hodgkinianos
24. Molecular basis of lymphomagenesis
25. Bcl-2 and the regulation of programmed cell death
26. Expression of the bcl-2 gene product in follicular lymphoma
27. Expression of bcl-2 protein and Fas antigen in Non-Hodgkin's lymphomas
28. Major cytogenetic findings in non-Hodgkin's lymphoma
29. Evaluation of bcl-2 protein expression and (14;18) translocation prognostic markers in follicular lymphoma
30. Bcl-2 and other genomic alterations in the prognosis of large cell lymphoma
31. P53 and bcl-2 expression in high grade B cell lymphomas: Correlation with survival time
32. The p53 tumors suppressed gene
33. Prognostic implications of ploidy and proliferative activity in diffuse large cell lymphomas